Stockyfly One Page Analysis | Buy Stocks today

24/10/2025

Hikal Ltd

BSE: 524735 NSE: HIKAL

Pharmaceuticals

Financial Health Score: 69%

About the Company

Hikal is a partner to companies in the Pharmaceuticals, Crop Protection, and Specialty Chemicals industry. The company is in the business of supplying research services, active ingredients and intermediates for its customers. Hikal's manufacturing facilities have been inspected and approved by leading multinational companies in the Crop protection and Pharmaceutical sectors. The Crop protection facilities are located at Taloja and Mahad {Maharashtra). The Pharmaceutical manufacturing facilities are situated in Jigani (Bengaluru) and Panoli (Gujarat). Hikal's R & D facilities are located in Pune.

Pros

Company has been maintaining a healthy dividend payout of 17.0%

Cons

Stock is trading at 2.52 times its book value
Company has low interest coverage ratio.
The company has delivered a poor sales growth of 4.29% over past five years.
Company has a low return on equity of 6.81% over last 3 years.

Stock PE: 294

ROCE: 9.85

Market Cap: 2995 Cr.

Book Value: 96.8

ROE: 7.39

Face Value: 2

Credit Report: View PDF

HIKAL - Price Chart

Volume Chart

Last 30 Days Bulk Deals

SL#	Symbol	Name	Date	Client	Buy/Sell	Quantity	Price	Remark
1	HIKAL	Hikal Limited	10/12/2025	HRTI PRIVATE LIMITED	SELL	1,675,248	251	-
2	HIKAL	Hikal Limited	10/12/2025	HRTI PRIVATE LIMITED	BUY	1,732,055	251	-
SL#	Symbol	Name	Date	Client	Buy/Sell	Quantity	Price	Remark

Technical Indicators

Today's OPEN >= LOW and HIGH=CLOSE	No
Is a 7 Days Breakout ?	No
3 Days Consecutive Volume Spike:	No
2 Days Consecutive Price Hike:	No
Above 20 MA ?	Below
Above 50 MA ?	Below
Above 100 MA ?	Below
Above 200 MA ?	Below